Nav: Home

Nanovaccine boosts immunity in sufferers of metabolic syndrome

March 28, 2019

ITHACA, N.Y. - A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria - a population that shows resistance to traditional flu and polio vaccines.

The study is the first to explore the interrelationship among nanomaterials, immune responses and the microbiome, an increasingly important area of research. The microbiome - the collection of microorganisms living in the body - is believed to play a critical role in human health.

"This paper highlights how the microbiome can impact our engineered vaccines and how we can overcome these problems by developing advanced materials," said Ankur Singh, assistant professor in the Sibley School of Mechanical and Aerospace Engineering (MAE) and the Meinig School of Biomedical Engineering (BME).

Singh is senior author of "Immunomodulatory Nanogels Overcome Restricted Immunity in a Murine Model of Gut Microbiome-Mediated Metabolic Syndrome," which published March 27 in Science Advances. The paper's first author is Matthew Mosquera, a doctoral student in engineering.

"This work opens up a new, very exciting area of investigation into how biological factors and underlying disease conditions impact the performance of established nanovaccines," said Singh, who is also a member of the Englander Institute for Precision Medicine at Weill Cornell Medicine and the newly formed Cornell Center for Immunology. "More importantly, it shows how you can use these engineered materials and make them more workable across a wider population to overcome immunity to vaccines."

More than a third of Americans and a quarter of people worldwide are believed to suffer from metabolic syndrome, an umbrella for several disorders including obesity, inflammation and insulin resistance.

The gut microbiome is among the factors that can cause metabolic syndrome, and researchers are interested in microbiome-induced metabolic syndrome because of evidence linking both the microbiome and metabolic disorders to the immune system.

"Understanding how the microbiome affects future engineered vaccines is of utmost importance from a public health perspective," said Ilana Brito, assistant professor of biomedical engineering and a co-author of the paper. "This research will open up new avenues for exploring how specific components of the microbiome alter immune responses. When engineering new vaccines, it'll be important to design materials that are effective across a diversity of microbiome compositions."

Previous research showed that traditional human flu and polio vaccines fail in mice that have metabolic disorders caused by disruptions to their gut biomes. "That motivated us to look into what happens with nanovaccines, which can be better than soluble vaccines, to better understand the role of underlying obesity and inflammation that develops in gut alterations," Singh said.

Nanovaccines, which are generally composed of nanomaterials, can be taken up by cells in the immune system and have been found to induce stronger immunity than traditional soluble vaccines in pre-clinical models.

But researchers found that the most widely used type of nanovaccine, made of poly(lactic-co-glycolic acid) (PLGA), is not very effective in mice with gut-initiated metabolic syndrome. When researchers tested PLGA nanovaccines on the mice, it was less successful than they had expected, even with the addition of a widely used immune booster.

"We asked, are there ways to overcome this restricted response by engineering new nanomaterial vaccines?" Singh said. "Then we looked deeper into a new class of material that modulates the immune system, pyridine functionalized poly(2-hydroxyethyl methacrylate), the potential of which we recently discovered."

The new material formed a stable nanogel with protein antigens, which was found to be effective under gut-initiated metabolic syndrome conditions. Working with Cynthia Leifer, associate professor of immunology in the College of Veterinary Medicine, the group discovered that this new material stimulates a receptor that recognizes pathogenic danger signs on microbes.

"This study is important because it shows that these nanogels can supply both antigen and adjuvant without the need for an extra immune booster, which likely contributes to their stronger immune activation and ability to overcome limitations imposed by diseases or altered microbiomes," Leifer said. "Immunomodulatory therapies are a hot topic, and materials-based immunomodulation approaches are in their infancy. There is so much that can be done with them."

While it has been established that the microbiome impacts the immune system, these findings suggest that nanovaccines can influence the microbiome in return.

"Nanomaterials can modulate the composition of the gut microbiome - I think that's of tremendous importance to the entire field and could have implications in material design," he said. "Whether it's a causative effect or the reason behind this is not very well understood - there are several hypotheses that remain to be tested, so this will be future work for us."
-end-
Other contributors to the study were: Christopher Hernandez, associate professor in MAE and BME; doctoral students Sungwoong Kim, Kristine Lai, Hao Zhou and Marysol Luna; Tina Jing '18; Jason Guss, Ph.D. '18; and Pooja Reddy '20.

The research was supported by grants from the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, the National Institute of Biomedical Imaging and Bioengineering, and the National Science Foundation.

Cornell University has dedicated television and audio studios available for media interviews supporting full HD, ISDN and web-based platforms.

Cornell University

Related Immune System Articles:

Memory training for the immune system
The immune system will memorize the pathogen after an infection and can therefore react promptly after reinfection with the same pathogen.
Immune system may have another job -- combatting depression
An inflammatory autoimmune response within the central nervous system similar to one linked to neurodegenerative diseases such as multiple sclerosis (MS) has also been found in the spinal fluid of healthy people, according to a new Yale-led study comparing immune system cells in the spinal fluid of MS patients and healthy subjects.
COVID-19: Immune system derails
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.
Immune cell steroids help tumours suppress the immune system, offering new drug targets
Tumours found to evade the immune system by telling immune cells to produce immunosuppressive steroids.
Immune system -- Knocked off balance
Instead of protecting us, the immune system can sometimes go awry, as in the case of autoimmune diseases and allergies.
Too much salt weakens the immune system
A high-salt diet is not only bad for one's blood pressure, but also for the immune system.
Parkinson's and the immune system
Mutations in the Parkin gene are a common cause of hereditary forms of Parkinson's disease.
How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.
Immune system upgrade
Theoretically, our immune system could detect and kill cancer cells.
Using the immune system as a defence against cancer
Research published today in the British Journal of Cancer has found that a naturally occurring molecule and a component of the immune system that can successfully target and kill cancer cells, can also encourage immunity against cancer resurgence.
More Immune System News and Immune System Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Warped Reality
False information on the internet makes it harder and harder to know what's true, and the consequences have been devastating. This hour, TED speakers explore ideas around technology and deception. Guests include law professor Danielle Citron, journalist Andrew Marantz, and computer scientist Joy Buolamwini.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

How to Win Friends and Influence Baboons
Baboon troops. We all know they're hierarchical. There's the big brutish alpha male who rules with a hairy iron fist, and then there's everybody else. Which is what Meg Crofoot thought too, before she used GPS collars to track the movements of a troop of baboons for a whole month. What she and her team learned from this data gave them a whole new understanding of baboon troop dynamics, and, moment to moment, who really has the power.  This episode was reported and produced by Annie McEwen. Support Radiolab by becoming a member today at Radiolab.org/donate.